Carderock Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,478
| Closed | -$527K | – | 82 |
|
|
2021
Q3 | $527K | Sell |
2,478
-18,769
| -88% | -$4.32M | 0.15% | 63 |
|
|
2021
Q2 | $5.18M | Sell |
21,247
-4,584
| -18% | -$1.13M | 1.42% | 31 |
|
|
2021
Q1 | $6.43M | Buy |
25,831
+178
| +0.7% | +$42.5K | 1.92% | 18 |
|
|
2020
Q4 | $5.9M | Sell |
25,653
-89
| -0.3% | -$20.5K | 1.78% | 21 |
|
|
2020
Q3 | $6.54M | Sell |
25,742
-58
| -0.2% | -$14.4K | 2.21% | 13 |
|
|
2020
Q2 | $6.08M | Sell |
25,800
-186
| -0.7% | -$42.4K | 2.24% | 14 |
|
|
2020
Q1 | $5.27M | Sell |
25,986
-2,812
| -10% | -$614K | 2.42% | 11 |
|
|
2019
Q4 | $6.94M | Buy |
28,798
+496
| +2% | +$109K | 2.33% | 10 |
|
|
2019
Q3 | $5.48M | Sell |
28,302
-2,500
| -8% | -$480K | 2.02% | 19 |
|
|
2019
Q2 | $5.68M | Buy |
30,802
+793
| +3% | +$142K | 2.14% | 14 |
|
|
2019
Q1 | $5.7M | Buy |
30,009
+5,392
| +22% | +$1.03M | 2.33% | 11 |
|
|
2018
Q4 | $4.79M | Sell |
24,617
-204
| -0.8% | -$39.8K | 2.48% | 12 |
|
|
2018
Q3 | $5.14M | Buy |
24,821
+119
| +0.5% | +$23.5K | 2.03% | 17 |
|
|
2018
Q2 | $4.56M | Sell |
24,702
-2,098
| -8% | -$371K | 1.97% | 19 |
|
|
2018
Q1 | $4.57M | Buy |
26,800
+101
| +0.4% | +$18.5K | 2.02% | 17 |
|
|
2017
Q4 | $4.64M | Sell |
26,699
-1,181
| -4% | -$209K | 2.05% | 18 |
|
|
2017
Q3 | $5.2M | Buy |
27,880
+510
| +2% | +$90.4K | 2.34% | 11 |
|
|
2017
Q2 | $4.71M | Sell |
27,370
-259
| -0.9% | -$42.1K | 2.13% | 18 |
|
|
2017
Q1 | $4.53M | Buy |
27,629
+848
| +3% | +$141K | 2.1% | 17 |
|
|
2016
Q4 | $3.92M | Sell |
26,781
-383
| -1% | -$57.6K | 1.95% | 21 |
|
|
2016
Q3 | $4.53M | Buy |
27,164
+754
| +3% | +$128K | 2.27% | 14 |
|
|
2016
Q2 | $4.02M | Buy |
26,410
+4,459
| +20% | +$693K | 2.13% | 21 |
|
|
2016
Q1 | $3.29M | Sell |
21,951
-117
| -0.5% | -$17.4K | 1.69% | 27 |
|
|
2015
Q4 | $3.58M | Buy |
22,068
+1,662
| +8% | +$261K | 1.86% | 24 |
|
|
2015
Q3 | $2.82M | Sell |
20,406
-2,480
| -11% | -$391K | 1.57% | 27 |
|
|
2015
Q2 | $3.51M | Sell |
22,886
-55
| -0.2% | -$8.81K | 1.76% | 25 |
|
|
2015
Q1 | $3.67M | Sell |
22,941
-106
| -0.5% | -$16.7K | 1.78% | 27 |
|
|
2014
Q4 | $3.67M | Buy |
23,047
+104
| +0.5% | +$16.2K | 1.81% | 27 |
|
|
2014
Q3 | $3.22M | Buy |
22,943
+4,912
| +27% | +$641K | 1.65% | 30 |
|
|
2014
Q2 | $2.13M | Buy |
18,031
+384
| +2% | +$44.5K | 1.11% | 36 |
|
|
2014
Q1 | $2.18M | Buy |
17,647
+931
| +6% | +$113K | 1.11% | 35 |
|
|
2013
Q4 | $1.91M | Buy |
+16,716
| New | +$1.9M | 1% | 39 |
|
Other funds holding AMGN
Carderock Capital Management's AMGN Position: Q4 2021 in Review
Carderock Capital Management sold out of Amgen (AMGN) in Q4 2021, closing a stake of 2,478 shares — an estimated $527K sold.
Carderock Capital Management first reported a position in AMGN in Q4 2013 and held it in 32 quarters. The position peaked at $6.94M in Q4 2019. 2,294 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.
- Carderock Capital Management reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
- Carderock Capital Management sold 2,478 Amgen shares in Q4 2021, an estimated $527K.
- Carderock Capital Management first reported a position in Amgen in Q4 2013 and held it in 32 quarters.
- Carderock Capital Management's Amgen position peaked at $6.94M in Q4 2019.
- 2,294 funds tracked by Wall St. Rank held Amgen as of Q4 2021.
Based on Carderock Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.